title: [Polymyositis and dermatomyositis in childhood].
abstract: Authors report clinical and laboratory findings, treatment and evolution of six girls and three boys aged between 20 months and 13 years, diagnosed of juvenile polymyositis-dermatomyositis in the last seven years. Presenting symptoms were asthenia and proximal muscle weakness; in 3 cases characteristic skin lesions were associated. All were treated initially with prednisone p.o. (1-2 mg/kg/day) response being favourable in seven. Two patients with chronic evolution were treated with methotrexate and IV bolus of methylprednisolone.
authors.affiliation: Departamento de Pediatría, Hospital General de Galicia, Facultad de Medicina, Universidad de Santiago de Conpostela.
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez Núñez
authors.forename: J M
authors.initials: JM
authors.lastname: Fernández Bustillo
authors.forename: E
authors.initials: E
authors.lastname: Rodríguez Pérez
authors.forename: I
authors.initials: I
authors.lastname: Novo Rodríguez
authors.forename: E
authors.initials: E
authors.lastname: Pérez Becerra
authors.forename: J
authors.initials: J
authors.lastname: Peña Guitián
authors.forename: M
authors.initials: M
authors.lastname: Castro Gago
mesh_terms: D000293:Adolescent; D002114:Calcinosis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D011241:Prednisone; D008775:Methylprednisolone; D008727:Methotrexate
vernacular_title: Poliomiositis y dermatomiositis en la infancia.